revumenib
syndax pharma
['augment,data', 'leukemia', 'revumenib', 'augment101', 'augment,trial', 'syndax', '$sndx']
#syndax announces positive updated data from phase 1 portion of #augment101 trial of #revumenib in patients with #acuteleukemias during oral presentations at #ash22 $sndx 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.